Long-term safety and effectiveness of natalizumab treatment in clinical practice: 10 years of real-world data from the Tysabri Observational Program (TOP)

OBJECTIVE: The Tysabri Observational Programme (TOP), which began >10 years ago, is an open-label, multinational, prospective observational study evaluating the long-term safety and effectiveness of natalizumab in relapsing-remitting multiple sclerosis patients. METHODS: These data provide a 10-y...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Neurol Neurosurg Psychiatry
Autores principales: Butzkueven, Helmut, Kappos, Ludwig, Wiendl, Heinz, Trojano, Maria, Spelman, Tim, Chang, Ih, Kasliwal, Rachna, Jaitly, Seema, Campbell, Nolan, Ho, Pei-Ran, Licata, Stephanie
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2020
Materias:
Multiple Sclerosis
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7279201/
https://ncbi.nlm.nih.gov/pubmed/32234967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2019-322326
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares